Flavivirus Laboratory, Oswaldo Cruz Institute, Rio de Janeiro, Brazil.
PLoS Negl Trop Dis. 2011 May 3;5(5):e1147. doi: 10.1371/journal.pntd.0001147.
/
Dengue is the most important arthropod borne viral disease worldwide in terms of morbidity and mortality and is caused by any of the four serotypes of dengue virus (DENV-1 to 4). Brazil is responsible for approximately 80% of dengue cases in the Americas, and since the introduction of dengue in 1986, a total of 5,944,270 cases have been reported including 21,596 dengue hemorrhagic fever and 874 fatal cases. DENV can infect many cell types and cause diverse clinical and pathological effects. The goal of the study was to investigate the usefulness of NS1 capture tests as an alternative tool to detect DENV in tissue specimens from previously confirmed dengue fatal cases (n = 23) that occurred in 2002 in Brazil.
METHODOLOGY/PRINCIPAL FINDINGS: A total of 74 tissue specimens were available: liver (n = 23), lung (n = 14), kidney (n = 04), brain (n = 10), heart (n = 02), skin (n = 01), spleen (n = 15), thymus (n = 03) and lymph nodes (n = 02). We evaluated three tests for NS1 antigen capture: first generation Dengue Early ELISA (PanBio Diagnostics), Platelia NS1 (BioRad Laboratories) and the rapid test NS1 Ag Strip (BioRad Laboratories). The overall dengue fatal case diagnosis based on the tissues analyzed by Dengue Early ELISA, Platelia NS1 and the NS1 Ag Strip was 34.7% (08/23), 60.8% (14/23) and 91.3% (21/23), respectively. The Dengue Early ELISA detected NS1 in 22.9% (17/74) of the specimens analyzed and the Platelia NS1 in 45.9% (34/74). The highest sensitivity (78.3%; 58/74) was achieved by the NS1 Ag Strip, and the differences in the sensitivities were statistically significant (p<0.05). The NS1 Ag Strip was the most sensitive in liver (91.3%; 21/23), lung (71.4%; 10/14), kidney (100%; 4/4), brain (80%; 8/10), spleen (66.6%, 10/15) and thymus (100%, 3/3) when compared to the other two ELISA assays.
CONCLUSIONS/SIGNIFICANCE: This study shows the DENV NS1 capture assay as a rapid and valuable approach to postmortem dengue confirmation. With an increasing number of DHF and fatal cases, the availability of new approaches useful for cases confirmation plays an important tool for the disease surveillance.
登革热是全球发病率和死亡率最高的虫媒病毒病,由登革病毒(DENV-1 至 4)的 4 种血清型引起。巴西负责美洲约 80%的登革热病例,自 1986 年登革热出现以来,共报告了 5944270 例病例,包括 21596 例登革出血热和 874 例死亡病例。DENV 可感染多种细胞类型,并导致不同的临床和病理影响。本研究的目的是研究 NS1 捕获试验作为替代工具检测巴西 2002 年确诊的 23 例登革热死亡病例(n=23)组织标本中 DENV 的有用性。
方法/主要发现:共获得 74 份组织标本:肝脏(n=23)、肺(n=14)、肾(n=04)、脑(n=10)、心(n=02)、皮肤(n=01)、脾(n=15)、胸腺(n=03)和淋巴结(n=02)。我们评估了三种 NS1 抗原捕获检测方法:第一代登革热早期 ELISA(PanBio Diagnostics)、Platelia NS1(BioRad Laboratories)和快速检测 NS1 Ag Strip(BioRad Laboratories)。基于分析的组织,登革热早期 ELISA、Platelia NS1 和 NS1 Ag Strip 对登革热致死病例的总体诊断率分别为 34.7%(08/23)、60.8%(14/23)和 91.3%(21/23)。登革热早期 ELISA 检测到 22.9%(17/74)的标本中存在 NS1,Platelia NS1 检测到 45.9%(34/74)。NS1 Ag Strip 的灵敏度最高(78.3%;58/74),且灵敏度差异具有统计学意义(p<0.05)。NS1 Ag Strip 在肝脏(91.3%;21/23)、肺(71.4%;10/14)、肾(100%;4/4)、脑(80%;8/10)、脾(66.6%;10/15)和胸腺(100%;3/3)中的检测灵敏度均高于其他两种 ELISA 检测法。
结论/意义:本研究表明,DENV NS1 捕获检测法是一种快速而有价值的登革热死后确认方法。随着登革热重症和死亡病例的增加,新的有用方法的出现对疾病监测具有重要意义。